SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002674
Filing Date
2020-04-29
Accepted
2020-04-29 08:06:41
Documents
7
Period of Report
2020-06-02
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241492zdef14a.htm DEF 14A 1015773
2 G106359.JPG g106359.jpg GRAPHIC 14631
3 G112243.JPG g112243.jpg GRAPHIC 7644
4 G873491.JPG g873491.jpg GRAPHIC 32234
5 G538981.JPG g538981.jpg GRAPHIC 31174
6 G153882BGI001.JPG g153882bgi001.jpg GRAPHIC 113625
7 G153882BGI002.JPG g153882bgi002.jpg GRAPHIC 106933
  Complete submission text file 0001047469-20-002674.txt   1439519
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10865 | Film No.: 20827494
SIC: 2834 Pharmaceutical Preparations